BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

«Ral Gtp-Binding Proteins

Below is an extended Ral Gtp-Binding Proteins research listing. Click here to return to the Ral Gtp-Binding Proteins main in depth entry.

Recent Publications on Ral Gtp-Binding Proteins:

The RalA GTPase is a central regulator of insulin exocytosis from pancreatic islet beta cells.
RalA is a small GTPase that is thought to facilitate exocytosis through...
Direct Link
19th August, 2008
Diabetes and Obesity Program, Garvan Institute of Medical Research,
Guanine exchange factor RalGDS mediates exocytosis of Weibel-Palade bodies from endothelial cells.
The small GTP-binding protein Ral has been implicated in regulated...
Direct Link
18th July, 2008
Department of Plasma Proteins, Sanquin Research and Landsteiner Laboratory
Characterization of RalB-Sec5-TBK1 function in human oncogenesis.
The Ras-like GTPases, RalA and RalB, are key components of the oncogenic...
Direct Link
20th June, 2008
Department of Cell Biology, University of Texas Southwestern Medical
Regulation of platelet dense granule secretion by the Ral GTPase-exocyst pathway.
Non-hydrolyzable GTP analogues, such as guanosine 5'-(beta,...
Direct Link
18th June, 2008
Department of Cardiovascular Medicine and Frontier Technology Center,
The small GTPase Ral mediates SDF-1-induced migration of B cells and multiple myeloma cells.
Chemokine-controlled migration plays a critical role in B-cell...
Direct Link
16th May, 2008
Department of Pathology, Academic Medical Center, University of Amsterdam,
Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.
Geranylgeranyltransferase I inhibitors (GGTIs) are presently undergoing...
Direct Link
28th March, 2008
Drug Discovery Program, The H. Lee Moffitt Cancer Center & Research
Phospholipase D provides a survival signal in human cancer cells with activated H-Ras or K-Ras.
Phospholipase D (PLD) is elevated in rodent fibroblasts expressing...
Direct Link
18th March, 2008
Department of Biological Sciences, Hunter College of The City University
RAP-1 and the RAL-1/exocyst pathway coordinate hypodermal cell organization in Caenorhabditis elegans.
The small Ras-like GTPase Rap1 has been identified as a regulator of...
Direct Link
8th March, 2008
Department of Physiological Chemistry, Centre for Biomedical Genetics, UMC
Ral GTPases and cancer: linchpin support of the tumorigenic platform.
A confluence of recent observations has indicted the Ras-family G-proteins...
Direct Link
22nd February, 2008
Department of Cell Biology, University of Texas Southwestern Medical
Activation of the RalGEF/Ral pathway promotes prostate cancer metastasis to bone.
A hallmark of metastasis is organ specificity; however, little is known...
Direct Link
6th December, 2007
Cell and Cancer Biology Branch, Center for Cancer Research, National
PP2A: unveiling a reluctant tumor suppressor.
Although evidence has suggested that the serine/threonine protein...
Direct Link
6th December, 2007
Department of Pharmacology, University of Texas Southwestern Medical
Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76).
RalBP1, a multifunctional protein implicated in cancer cell proliferation,...
Direct Link
24th October, 2007
Department of Molecular Physiology and Biological Physics, University of
Ral-GTPase interacts with the beta1 subunit of Na+/K+-ATPase and is activated upon inhibition of the Na+/K+ pump.
Na+/K+-ATPase functions as both an ion pump and a signal transducer....
Direct Link
17th October, 2007
Department of Oral Biology, University of Manitoba, 744 Bannatyne Avenue,
Expression of ral GTPases, their effectors, and activators in human bladder cancer.
PURPOSE: The Ral family of small G proteins has been implicated in...
Direct Link
7th September, 2007
Department of Molecular Physiology, University of Virginia,
The tumor suppressor PP2A Abeta regulates the RalA GTPase.
The serine-threonine protein phosphatase 2A (PP2A) is a heterotrimeric...
Direct Link
19th July, 2007
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard
 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.

BioPortfolio logo

Valid XHTML 1.0 Transitional